PetCaseFinder

Peer-reviewed veterinary case report

Antibiotic resistance in Staphylococcus intermedius from dog skin

By Ganiere, J-P et al.·Published in Journal of veterinary medicine. B, Infectious diseases and veterinary public health·2005·Ecole Nationale V&#xe9, France·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma.

Species:
dog

Plain-English summary

A study found that many dogs with skin infections caused by Staphylococcus intermedius bacteria are resistant to common antibiotics. Out of 50 samples from dogs with pyoderma, about 62% were resistant to penicillin, and many also showed resistance to other antibiotics like sulphonamides and oxytetracycline. However, a combination of clavulanic acid and amoxicillin, along with some other antibiotics, remained effective against these bacteria. This means that if your dog has a skin infection, your vet might consider using these effective treatments instead of the more commonly resisted antibiotics.

People also search for: dog skin infection antibiotics · Staphylococcus intermedius treatment · resistant bacteria in dogs

Abstract

A total of 50 Staphylococcus intermedius strains isolated in France from canine pyodermas in 2002 were investigated for their susceptibility to various antimicrobial drugs. Antimicrobial susceptibility was assessed using a 2-fold serial dilution method in Mueller-Hinton agar, and the minimal inhibitory concentrations (MICs) were determined. About 62% of the 50 strains tested were producers of beta-lactamase and categorized as penicillin-resistant. About 26% demonstrated resistance to sulphonamides, 46% to oxytetracycline, 30% to chloramphenicol, 28% to streptomycin, kanamycin, neomycin or erythromycin, 22% to clindamycin, 6% to doxycycline, 2% to gentamicin, enrofloxacin, marbofloxacin or pradofloxacin. Acquired resistance was not observed to a clavulanic acid-amoxicillin combination, oxacillin, cephalosporins (cephalexin, ceftiofur and cefquinome), trimethoprim, a sulphamethoxazole-trimethoprim combination and florfenicol. About 42% were simultaneously resistant to three or more antimicrobial classes (multiresistance). All isolates with acquired resistance to erythromycin were also resistant to streptomycin and neomycin/kanamycin. About 22% of isolates exhibited cross-resistance between erythromycin and clindamycin and all clindamycin-resistant isolates also exhibited resistance to erythromycin. Resistance to penicillin, oxytetracycline and chloramphenicol was also positively associated with resistance to erythromycin and streptomycin.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/15702997/